TCL Archive Paul Marks To Retire As President, CEO Of Memorial Sloan-Kettering Cancer Center December 11, 1998
TCL Archive Gleevec Maintenance Therapy Showed Significant Benefits At Three Years in Phase III Trial April 27, 2012
TCL Archive Blueprint Group co-chairman Mark Ratain says group seeks “the perfect peer review system,” but a member’s email questions the proposal. August 13, 2004